Rakuten Medical, Inc. and Shimadzu Corporation announced a joint development and commercialization agreement to advance a medical device for use on the Illuminox platform. This partnership will allow for the development of a medical device using optical measurement technologies to support cancer treatment by photoimmunotherapy. Based on this agreement, both companies will use their expertise to work toward the joint development of technology that will allow visualization, measurement, and recording of the reaction of the dye to light illumination in real-time. This will allow for optimization of light irradiation depending on the tumor. Both companies will cooperate to aim for commercialization of the medical device using the technology on a worldwide basis.